We’re delighted to announce that Doser Medical has successfully passed the Factory Acceptance Test (FAT) for our innovative 3D compounding system at the Leiden University Medical Center (LUMC). The FAT, a key milestone in quality control and assurance, confirms that our technology aligns with the required specifications and adheres to the highest standards of quality.
The completion of the FAT marks another significant stride for Doser Medical’s mission to revolutionize personalized patient care through technology. “We’re excited to have successfully passed the Factory Acceptance Test, enabling us to install our 3D Printer at LUMC,” said Thomas de Boer, CTO of Doser Medical. “I’m incredibly proud of my team and what we’ve accomplished in such a short timeframe. I firmly believe that our technology has the potential to redefine pharmacy, providing patients with the care they specifically need, not just what is conveniently available.”
This success at LUMC affirms the swift development of Doser Medical’s groundbreaking technology, and we are eager to extend our collaborations with other hospital pharmacists. We aim to deliver bespoke patient treatments universally, shaping the future of healthcare one dose at a time.
We extend our gratitude to the LUMC for their continuous collaboration and eagerly anticipate the benefits our new 3D Printer will bring to their patients.
For hospital pharmacists intrigued by Doser Medical’s cutting-edge solutions and eager to explore how our technology could enhance their patient care, we invite you to connect with us and initiate a conversation.
Our dedicated team is committed to comprehending your unique needs and challenges. Together, we can craft a solution perfectly tailored to your hospital pharmacy’s requirements, enabling us to improve patient care, one personalized dose at a time.
